DESCRIPTION
With changes to AMP, increased transparency and the uncertainty of AWP’s future, it is now more important than ever to have a comprehensive pricing strategy in place. To ensure your rebate reimbursement exposure is limited, that you are being adequately reimbursed for drugs provided to beneficiaries or that pricing for government programs is not negatively affecting commercial prices, you need to understand the changes that are taking place and devise a strategy to deal with them.
Nearly every major component of the pharmaceutical industry, as well as public and private healthcare, is in a tailspin. R&D, IP, product and formulary placement, and patient access all have been touched by these reforms in some way.
These newest reforms are at the root of new and continuing anxieties over pricing transparency and fraud and abuse. They also exacerbate the scope of existing dilemmas, such as public and private pricing litigation and criminal enforcement actions. Will Medicare Part D pricing and AMP reform under the DRA bring something akin to the long-waged civil and criminal AWP suits?
Hear from those in the trenches of pricing and reimbursement, and hear first-hand how the new landscape is evolving. Network with your peers and benefit from the written materials prepared by the speakers especially for this program.
Foley Hoag Partner, Nick Theodorou, will be moderating the Federal Pricing Enforcement Update.
What novel theories will the federal government pursue under Medicare Part D and the other pricing reforms under the DRA? In this interactive roundtable, federal prosecutors will speak about various cases and their results, the lessons to be learned from them, and the measures companies can take to ensure they will not become targets of investigation. Points of discussion will included:
- Review of recent federal, civil and criminal prosecutions
- Discussion of DOJ initiatives, including issues arising under Medicare Part D
- Examination of compliance measures geared toward reducing the risk of criminal and civil prosecutions
For full event details visit americanconference.com.